Indianapolis Business Journal

Deal after deal, Indianapolis-based Eli Lilly and Co. is using the fruits of its success from developing blockbuster GLP-1 medicines to build a bridge over a looming patent cliff. Daniel Bradley reports that Lilly so far this year has spent $21 billion to acquire six biotech companies and crafted licensing deals worth up to $19 billion. Also in this week’s issue, Joey Harris explains how data centers handle the need for large sources of backup power. And Susan Orr takes a deep dive into Trump Accounts, the new investment option for new parents.